Search research articles
Contact Us
Filters
Showing results (71-80 of 327) with videos related to
Page
of 33
Sort By:
Alcohol, Clinical & Experimental Research
|
August 7, 2025
Profiles of impulsivity and alcohol use: Unveiling personality, cognitive traits, and DSM diagnoses
Chloe Lau, Danielle Downie, R Michael Bagby, et al.
Neuropsychiatric Disease and Treatment
|
May 10, 2011
Performance of Cpred/Cobs concentration ratios as a metric reflecting adherence to antidepressant drug therapy
Yan Feng, Marc R Gastonguay, Bruce G Pollock, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
March 28, 2006
A genetic algorithm-based, hybrid machine learning approach to model selection
Robert R Bies, Matthew F Muldoon, Bruce G Pollock, et al.
The Journal of Clinical Psychiatry
|
October 28, 2016
Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial
Hitoshi Sakurai, Takefumi Suzuki, Robert R Bies, et al.
Journal of Psychopharmacology (Oxford, England)
|
September 16, 2022
Cell-based serum anticholinergic activity assay and working memory in cognitively healthy older adults before and after scopolamine: An exploratory study
Susmita Chandramouleeshwaran, Zaid Ghazala, José N Nobrega, et al.
Psychopharmacology
|
September 15, 2004
Neuroendocrine response to intravenous citalopram in healthy control subjects: pharmacokinetic influences
Francis E Lotrich, Robert Bies, Matthew F Muldoon, et al.
Psychopharmacology Bulletin
|
October 17, 2003
An intent-to-treat method for enhancing analysis of clinical trials with rescue medication: a mixed-model approach
Patricia R Houck, Sati Mazumdar, Benoit H Mulsant, et al.
British Journal of Clinical Pharmacology
|
May 4, 2006
Paroxetine: population pharmacokinetic analysis in late-life depression using sparse concentration sampling
Yan Feng, Bruce G Pollock, Robert E Ferrell, et al.
Schizophrenia Research
|
December 3, 2014
Impaired insight into illness and cognitive insight in schizophrenia spectrum disorders: resting state functional connectivity
Philip Gerretsen, Mahesh Menon, David C Mamo, et al.
CNS Spectrums
|
February 24, 2004
Treatment considerations for anxiety in the elderly
Eric J Lenze, Bruce G Pollock, M Katherine Shear, et al.
Page
of 33
Search research articles
Search
Showing results (71-80 of 327) with videos related to
Sort By:
Page
of 33
Alcohol, Clinical & Experimental Research
|
August 7, 2025
Profiles of impulsivity and alcohol use: Unveiling personality, cognitive traits, and DSM diagnoses
Chloe Lau, Danielle Downie, R Michael Bagby, et al.
Neuropsychiatric Disease and Treatment
|
May 10, 2011
Performance of Cpred/Cobs concentration ratios as a metric reflecting adherence to antidepressant drug therapy
Yan Feng, Marc R Gastonguay, Bruce G Pollock, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
March 28, 2006
A genetic algorithm-based, hybrid machine learning approach to model selection
Robert R Bies, Matthew F Muldoon, Bruce G Pollock, et al.
The Journal of Clinical Psychiatry
|
October 28, 2016
Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial
Hitoshi Sakurai, Takefumi Suzuki, Robert R Bies, et al.
Journal of Psychopharmacology (Oxford, England)
|
September 16, 2022
Cell-based serum anticholinergic activity assay and working memory in cognitively healthy older adults before and after scopolamine: An exploratory study
Susmita Chandramouleeshwaran, Zaid Ghazala, José N Nobrega, et al.
Psychopharmacology
|
September 15, 2004
Neuroendocrine response to intravenous citalopram in healthy control subjects: pharmacokinetic influences
Francis E Lotrich, Robert Bies, Matthew F Muldoon, et al.
Psychopharmacology Bulletin
|
October 17, 2003
An intent-to-treat method for enhancing analysis of clinical trials with rescue medication: a mixed-model approach
Patricia R Houck, Sati Mazumdar, Benoit H Mulsant, et al.
British Journal of Clinical Pharmacology
|
May 4, 2006
Paroxetine: population pharmacokinetic analysis in late-life depression using sparse concentration sampling
Yan Feng, Bruce G Pollock, Robert E Ferrell, et al.
Schizophrenia Research
|
December 3, 2014
Impaired insight into illness and cognitive insight in schizophrenia spectrum disorders: resting state functional connectivity
Philip Gerretsen, Mahesh Menon, David C Mamo, et al.
CNS Spectrums
|
February 24, 2004
Treatment considerations for anxiety in the elderly
Eric J Lenze, Bruce G Pollock, M Katherine Shear, et al.
Page
of 33